ArticleCancer management and research2022

Italian Real-Life Experience on the Use of Mogamulizumab in Patients with Cutaneous T-Cell Lymphomas.

Laura Caruso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.